Open access
Jul 2026
snoRNAs: New players in CKD biomarkers
It is a clinical unmet need to identify novel biomarkers to improve diagnosis, prediction and prognosis, as well as response and pharmacodynamics of established and novel therapeutic interventions. Chronic kidney disease
L. Eliasson, Allan A. Vaag
· Molecular Therapy: Nucleic A... · 0 citations